4//SEC Filing
Bench David 4
Accession 0001213900-22-007979
CIK 0000316253other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 9:38 PM ET
Size
9.0 KB
Accession
0001213900-22-007979
Insider Transaction Report
Form 4
Bench David
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (to acquire Common Stock)
2022-02-11+87,500→ 87,500 totalExercise: $3.36From: 2023-02-11Exp: 2027-02-11→ Common Stock (87,500 underlying)
Holdings
- 55,400
Stock Option (to acquire Common Stock)
Exercise: $2.63From: 2022-01-11Exp: 2026-01-11→ Common Stock (55,400 underlying) - 1,295.767(indirect: By 401(k))
Common Stock, $0.01 Par Value
- 55,400
Stock Option (to acquire Common Stock)
Exercise: $2.20From: 2021-02-24Exp: 2025-02-24→ Common Stock (55,400 underlying)
Footnotes (2)
- [F1]Represents restricted shares granted subject the Company's discretionary matching contribution and non-elective employer contribution which vest ratable over four years of service, which began on December 23, 2019.
- [F2]The stock options have a three-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeother
Related Parties
1- filerCIK 0001797876
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 9:38 PM ET
- Size
- 9.0 KB